Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

ENvue Medical (FEED) EBIT Margin (2017 - 2025)

Historic EBIT Margin for ENvue Medical (FEED) over the last 11 years, with Q3 2025 value amounting to 311.22%.

  • ENvue Medical's EBIT Margin fell 532400.0% to 311.22% in Q3 2025 from the same period last year, while for Sep 2025 it was 351.77%, marking a year-over-year decrease of 2632200.0%. This contributed to the annual value of 140.03% for FY2024, which is 104700.0% up from last year.
  • ENvue Medical's EBIT Margin amounted to 311.22% in Q3 2025, which was down 532400.0% from 804.86% recorded in Q2 2025.
  • In the past 5 years, ENvue Medical's EBIT Margin registered a high of 1674.51% during Q4 2022, and its lowest value of 1275.73% during Q1 2021.
  • Over the past 5 years, ENvue Medical's median EBIT Margin value was 298.02% (recorded in 2023), while the average stood at 257.27%.
  • In the last 5 years, ENvue Medical's EBIT Margin skyrocketed by 19983800bps in 2022 and then crashed by -17341500bps in 2023.
  • Over the past 5 years, ENvue Medical's EBIT Margin (Quarter) stood at 323.87% in 2021, then soared by 617bps to 1674.51% in 2022, then tumbled by -104bps to 59.64% in 2023, then plummeted by -417bps to 308.56% in 2024, then fell by -1bps to 311.22% in 2025.
  • Its EBIT Margin was 311.22% in Q3 2025, compared to 804.86% in Q2 2025 and 180.68% in Q1 2025.